These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 17565561)

  • 1. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the clinical pharmacology of methamphetamine.
    Cruickshank CC; Dyer KR
    Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Driving under the influence of amphetamine and metamphetamine].
    Lia K; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic abnormalities in methamphetamine abusers.
    Haning W; Goebert D
    Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major physical and psychological harms of methamphetamine use.
    Darke S; Kaye S; McKetin R; Duflou J
    Drug Alcohol Rev; 2008 May; 27(3):253-62. PubMed ID: 18368606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
    Kay-Lambkin FJ
    Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine and meth mouth: an overview.
    Williams N; Covington JS
    J Tenn Dent Assoc; 2006; 86(4):32-5. PubMed ID: 17228534
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users.
    Kim DJ; Roh S; Kim Y; Yoon SJ; Lee HK; Han CS; Kim YK
    Neurosci Lett; 2005 Nov; 388(2):112-5. PubMed ID: 16039058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
    Volz TJ; Fleckenstein AE; Hanson GR
    Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine abuse and dentistry.
    Hamamoto DT; Rhodus NL
    Oral Dis; 2009 Jan; 15(1):27-37. PubMed ID: 18992021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.